Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - DEFERRED INCOME TAX
Deferred Income Tax NBIX - Neurocrine Biosciences, Inc.
-56.7 M
LAST VALUE
-276.64%
2 YEAR CAGR
-142.17%
5 YEAR CAGR
-67.46%
10 YEAR CAGR